Sarcoma, Secondary cancers, Soft tissue sarcoma
Results
Phase 2
This trial looked cediranib to treat alveolar soft part sarcoma that had spread.
The trial was supported by Cancer Research UK. It was open for people to join between 2011 and 2016. The team published the results in 2019.
Recruitment start: 11 May 2011
Recruitment end: 31 July 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Ian Judson
AstraZeneca
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Institute of Cancer Research (ICR)
NIHR Clinical Research Network: Cancer
The Royal Marsden NHS Foundation Trust
This is Cancer Research UK trial number CRUK/10/021.
Last reviewed: 02 Sept 2025
CRUK internal database number: 6173